RETA FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action – RETA
15 févr. 2022 16h45 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RETA
09 févr. 2022 17h15 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action – RETA
05 févr. 2022 11h36 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
ROSEN, A LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 18 Deadline in Securities Class Action – RETA
02 févr. 2022 12h04 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action – RETA
25 janv. 2022 16h56 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
DEADLINE ALERT for RDW, MARA, HOOD, and RETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
25 janv. 2022 11h15 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for RDW, MARA, HOOD, and RETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
20 janv. 2022 11h25 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for RDW, MARA, HOOD, and RETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
12 janv. 2022 12h05 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RETA
08 janv. 2022 18h45 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
DEADLINE ALERT for RDW, MARA, HOOD, and RETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
06 janv. 2022 11h15 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...